AIG-backed cancer and genetic disease developer BridgeBio Pharma has filed for a $225m initial public offering on the Nasdaq Global Market.
Month: May 2019
Stoke Therapeutics stakes out IPO spot
The genetic drug developer is targeting up to $86m in an IPO that would enable Alexandria Venture Investments to score an exit.
Corporates find New Horizon in $66m round
SoftBank China Venture Capital and Legend Capital contributed to a round that boosted the cancer screening device maker’s overall funding to more than $100m.
Google returns for KaiOS in $50m series B
Existing backer Google has reinvested in the mobile operating system developer to increase its overall funding to $79m.
Aurora orders up Blackmore acquisition
Aurora has announced it is set to buy the lidar system developer, which had raised more than $21m from investors including BMW i Ventures and Toyota AI Ventures.
Marui tailors funding for Fabric Tokyo
Marui Group has invested an undisclosed amount in tailored clothing e-commerce platform Fabric Tokyo in connection with a strategic partnership.
Ideaya realises $50m IPO
Ideaya priced its shares below their range to raise $50m, providing exits for Alphabet, WuXi AppTec, Celgene, Roche and Novartis.
Mars and JVP to explore R&D space
Mars has partnered Jerusalem Venture Partners in a venture that will involve them investing in Israel-based developers of food, agriculture and nutrition technologies.
Quick insights from our GCV Founders survey
In February and March 2019, we conducted a small pilot survey (n=31) of founders of businesses that have received corporate funding, which were referred to the survey by their corporate backers. We called it the “GCV Founders Survey” and it gave us some interesting insights.
Corporate venturing deal net: 20-24 May 2019
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Percepto pursues Hyundai to raise $15m
Hyundai-backed industrial security drone developer Percepto secured funding in a USVP-led series A round that boosted its overall equity financing to nearly $28m.
DoorDash jumps to $600m series G round
DoorDash is now valued at $12.6bn after securing funding in a series G round backed by SoftBank Vision Fund, taking its total funding to nearly $2bn.
AlloVir secures $120m funding allocation
The T-Cell therapy developer has received funding in a Gilead Sciences-backed series B round led by Fidelity Management and Research.
UnityPoint Health assembles $100m fund
UnityPoint Health has launched a corporate venturing arm, UnityPoint Health Ventures Innovation Fund, that will invest in areas such as digital health and medical devices.